Literature DB >> 15075440

Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.

Victoria Busby1, Steven Goossens, Petra Nowotny, Gillian Hamilton, Scott Smemo, Denise Harold, Dragana Turic, Luke Jehu, Amanda Myers, Meredith Womick, Daniel Woo, Danielle Compton, Lisa M Doil, Kristina M Tacey, Kit F Lau, Safa Al-Saraj, Richard Killick, Stuart Pickering-Brown, Pamela Moore, Paul Hollingworth, Nicola Archer, Catherine Foy, Sarah Walter, Corrine Lendon, Takeshi Iwatsubo, John C Morris, Joanne Norton, David Mann, Barbara Janssens, John Hardy, Michael O'Donovan, Lesley Jones, Julie Williams, Peter Holmans, Michael J Owen, Andrew Grupe, John Powell, Jolanda van Hengel, Alison Goate, Frans Van Roy, Simon Lovestone.   

Abstract

The gene encoding alpha-T-catenin, CTNNA3, is positioned within a region on chromosome 10, showing strong evidence of linkage to Alzheimer's disease (AD), and is therefore a good positional candidate gene for this disorder. We have demonstrated that alpha-T-catenin is expressed in human brain, and like other alpha-catenins, it inhibits Wnt signaling and is therefore also a functional candidate. We initially genotyped two single-nucleotide polymorphisms (SNPs) in the gene, in four independent samples comprising over 1200 cases and controls but failed to detect an association with either SNP. Similarly, we found no evidence for association between CTNNA3 and AD in a sample of subjects showing linkage to chromosome 10, nor were these SNPs associated with Abeta deposition in brain. To comprehensively screen the gene, we genotyped 30 additional SNPs in a subset of the cases and controls (n > 700). None of these SNPs was associated with disease. Although an excellent candidate, we conclude that CTNNA3 is unlikely to account for the AD susceptibility locus on chromosome 10.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15075440     DOI: 10.1385/NMM:5:2:133

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  28 in total

1.  Cadherin regulates dendritic spine morphogenesis.

Authors:  Hideru Togashi; Kentaro Abe; Akira Mizoguchi; Kanna Takaoka; Osamu Chisaka; Masatoshi Takeichi
Journal:  Neuron       Date:  2002-07-03       Impact factor: 17.173

2.  Full genome screen for Alzheimer disease: stage II analysis.

Authors:  Amanda Myers; Fabienne Wavrant De-Vrieze; Peter Holmans; Marian Hamshere; Richard Crook; Danielle Compton; Helen Marshall; David Meyer; Shantia Shears; Jeremy Booth; Dzanan Ramic; Heather Knowles; John C Morris; Nigel Williams; Nadine Norton; Richard Abraham; Pat Kehoe; Hywel Williams; Varuni Rudrasingham; Francis Rice; Peter Giles; Nigel Tunstall; Lesley Jones; Simon Lovestone; Julie Williams; Michael J Owen; John Hardy; Alison Goate
Journal:  Am J Med Genet       Date:  2002-03-08

3.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q.

Authors:  L Bertram; D Blacker; K Mullin; D Keeney; J Jones; S Basu; S Yhu; M G McInnis; R C Go; K Vekrellis; D J Selkoe; A J Saunders; R E Tanzi
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

4.  Susceptibility locus for Alzheimer's disease on chromosome 10.

Authors:  A Myers; P Holmans; H Marshall; J Kwon; D Meyer; D Ramic; S Shears; J Booth; F W DeVrieze; R Crook; M Hamshere; R Abraham; N Tunstall; F Rice; S Carty; S Lillystone; P Kehoe; V Rudrasingham; L Jones; S Lovestone; J Perez-Tur; J Williams; M J Owen; J Hardy; A M Goate
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

5.  Assessment of the CTNNA3 gene encoding human alpha T-catenin regarding its involvement in dilated cardiomyopathy.

Authors:  Barbara Janssens; Bhagyalaxmi Mohapatra; Matteo Vatta; Steven Goossens; Griet Vanpoucke; Patrick Kools; Tony Montoye; Jolanda van Hengel; Neil E Bowles; Frans van Roy; Jeffrey A Towbin
Journal:  Hum Genet       Date:  2002-12-05       Impact factor: 4.132

6.  Fine mapping of the alpha-T catenin gene to a quantitative trait locus on chromosome 10 in late-onset Alzheimer's disease pedigrees.

Authors:  Nilüfer Ertekin-Taner; James Ronald; Hideaki Asahara; Linda Younkin; Maria Hella; Shushant Jain; Eugene Gnida; Samuel Younkin; Daniel Fadale; Yasumasa Ohyagi; Adam Singleton; Leah Scanlin; Mariza de Andrade; Ronald Petersen; Neill Graff-Radford; Michael Hutton; Steven Younkin
Journal:  Hum Mol Genet       Date:  2003-10-14       Impact factor: 6.150

7.  cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif.

Authors:  E Schreiber; A Tobler; U Malipiero; W Schaffner; A Fontana
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

8.  Deletion in Catna2, encoding alpha N-catenin, causes cerebellar and hippocampal lamination defects and impaired startle modulation.

Authors:  Chankyu Park; William Falls; Jacqueline H Finger; Chantal M Longo-Guess; Susan L Ackerman
Journal:  Nat Genet       Date:  2002-06-24       Impact factor: 38.330

9.  alphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion.

Authors:  B Janssens; S Goossens; K Staes; B Gilbert; J van Hengel; C Colpaert; E Bruyneel; M Mareel; F van Roy
Journal:  J Cell Sci       Date:  2001-09       Impact factor: 5.285

10.  Antagonism of cell adhesion by an alpha-catenin mutant, and of the Wnt-signaling pathway by alpha-catenin in Xenopus embryos.

Authors:  R N Sehgal; B M Gumbiner; L F Reichardt
Journal:  J Cell Biol       Date:  1997-11-17       Impact factor: 10.539

View more
  21 in total

1.  Novel genes identified in a high-density genome wide association study for nicotine dependence.

Authors:  Laura Jean Bierut; Pamela A F Madden; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Ovide F Pomerleau; Gary E Swan; Joni Rutter; Sarah Bertelsen; Louis Fox; Douglas Fugman; Alison M Goate; Anthony L Hinrichs; Karel Konvicka; Nicholas G Martin; Grant W Montgomery; Nancy L Saccone; Scott F Saccone; Jen C Wang; Gary A Chase; John P Rice; Dennis G Ballinger
Journal:  Hum Mol Genet       Date:  2006-12-07       Impact factor: 6.150

2.  GWAS, cytomegalovirus infection, and schizophrenia.

Authors:  Jakob Grove; Anders D Børglum; Brad D Pearce
Journal:  Curr Behav Neurosci Rep       Date:  2014-12-01

3.  Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?

Authors:  Lars Bertram; Kristina Mullin; Michele Parkinson; Monica Hsiao; Thomas J Moscarillo; Steven L Wagner; K David Becker; Gonul Velicelebi; Deborah Blacker; Rudolph E Tanzi
Journal:  J Med Genet       Date:  2007-01       Impact factor: 6.318

4.  Effect of genetic variation in LRRTM3 on risk of Alzheimer disease.

Authors:  Christiane Reitz; Christopher Conrad; Katherine Roszkowski; Robert S Rogers; Richard Mayeux
Journal:  Arch Neurol       Date:  2012-07

5.  A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer.

Authors:  Kathryn A O'Donnell; Vincent W Keng; Brian York; Erin L Reineke; Daekwan Seo; Danhua Fan; Kevin A T Silverstein; Christina T Schrum; Wei Rose Xie; Loris Mularoni; Sarah J Wheelan; Michael S Torbenson; Bert W O'Malley; David A Largaespada; Jef D Boeke
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-03       Impact factor: 11.205

Review 6.  Alpha T-catenin (CTNNA3): a gene in the hand is worth two in the nest.

Authors:  James D Smith; Maria H Meehan; John Crean; Amanda McCann
Journal:  Cell Mol Life Sci       Date:  2011-05-20       Impact factor: 9.261

7.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

8.  An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.

Authors:  Todd L Edwards; Margaret Pericak-Vance; Johnny R Gilbert; Jonathan L Haines; Eden R Martin; Marylyn D Ritchie
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

Review 9.  Genetics of Alzheimer's disease: a centennial review.

Authors:  Nilüfer Ertekin-Taner
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

10.  GATA-4 and MEF2C transcription factors control the tissue-specific expression of the alphaT-catenin gene CTNNA3.

Authors:  Griet Vanpoucke; Steven Goossens; Bram De Craene; Barbara Gilbert; Frans van Roy; Geert Berx
Journal:  Nucleic Acids Res       Date:  2004-08-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.